Craig C. Hopkinson - 01 Dec 2022 Form 4 Insider Report for ALBIREO PHARMA, INC.

Role: Director
Signature: /s/ Jason Duncan, Attorney-in-fact
Issuer symbol: N/A
Transactions as of: 01 Dec 2022
Net transactions value: $0
Form type: 4
Filing time: 05 Dec 2022, 15:10:21 UTC
Previous filing: 24 Feb 2022
Next filing: 22 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALBO	Common Stock	Award	$0	+10,495		$0.000000	10,495	01 Dec 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs will vest in equal annual installments over three years from December 1, 2022 (but, in any case, to be fully vested on the day prior to the annual meeting for the third fiscal year that begins following the date of grant), subject to the director's continued service on the issuer's board of directors on the applicable vesting dates.
F2	Represents 10,495 restricted stock units.

Content

Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs will vest in equal annual installments over three years from December 1, 2022 (but, in any case, to be fully vested on the day prior to the annual meeting for the third fiscal year that begins following the date of grant), subject to the director's continued service on the issuer's board of directors on the applicable vesting dates.

Represents 10,495 restricted stock units.